Early ribavirin treatment and avoidance of corticosteroids in hepatitis C virus (HCV)-positive liver transplant recipients: interim report of a prospective randomized trial.

Belli, L S; Alberti, A B; Rondinara, G F; de Carlis, L; Corti, A; Mazza, E; Airoldi, A; Cernuschi, A; de Gasperi, A; Forti, D; Pinzello, G B

Belli, L S; Alberti, A B; Rondinara, G F; de Carlis, L; Corti, A; Mazza, E; Airoldi, A; Cernuschi, A; de Gasperi, A; Forti, D; Pinzello, G B.

Affiliation

Belli LS; Divisione Medica "Crespi", Milano, Italy. isbelli@tin.it

Transplant Proc ; 33(1-2): 1353-4, 2001.

Article in En | MEDLINE | ID: mdl-11267324

Subject(s)

Adrenal Cortex Hormones/administration & dosage; Antiviral Agents/therapeutic use; Hepatitis C/prevention & control; Liver Transplantation/immunology; Ribavirin/therapeutic use; Drug Administration Schedule; Follow-Up Studies; Hepatitis C/enzymology; Humans; Interferons/therapeutic use; Liver/enzymology; Postoperative Complications/prevention & control; Prospective Studies; Secondary Prevention

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 2_ODS3 / 4_TD Database: MEDLINE Main subject: Antiviral Agents / Ribavirin / Liver Transplantation / Hepatitis C / Adrenal Cortex Hormones Type of study: Clinical_trials / Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Transplant Proc Year: 2001 Document type: Article

Search on Google

XML

PubMed Links